X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (765) 765
Book Chapter (3) 3
Book Review (3) 3
Book / eBook (1) 1
Conference Proceeding (1) 1
Magazine Article (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (341) 341
life sciences & biomedicine (334) 334
heart failure (293) 293
humans (267) 267
cardiovascular system & cardiology (243) 243
male (234) 234
cardiac & cardiovascular systems (231) 231
female (201) 201
aged (172) 172
middle aged (158) 158
abridged index medicus (141) 141
heart failure - physiopathology (130) 130
cardiovascular (113) 113
animals (72) 72
risk factors (68) 68
peripheral vascular disease (64) 64
aged, 80 and over (63) 63
natriuretic peptides (63) 63
cardiology and cardiovascular medicine (61) 61
dogs (61) 61
heart failure - drug therapy (60) 60
research (58) 58
echocardiography (54) 54
heart failure - diagnosis (53) 53
stroke volume (52) 52
prognosis (51) 51
analysis (50) 50
hypertension (50) 50
general & internal medicine (48) 48
mortality (47) 47
stroke volume - physiology (47) 47
diastole (46) 46
heart failure - epidemiology (46) 46
medicine, general & internal (45) 45
treatment outcome (45) 45
blood pressure (42) 42
care and treatment (41) 41
natriuretic peptide, brain - blood (41) 41
epidemiology (39) 39
heart failure - mortality (39) 39
cardiology (37) 37
follow-up studies (37) 37
internal medicine (37) 37
heart failure with preserved ejection fraction (36) 36
retrospective studies (36) 36
adult (35) 35
cohort studies (32) 32
diagnosis (32) 32
heart failure - therapy (32) 32
hemodynamics (32) 32
peptides (32) 32
cardiac output (31) 31
cardiovascular disease (31) 31
heart (31) 31
time factors (31) 31
echocardiography, doppler (30) 30
prospective studies (30) 30
minnesota - epidemiology (29) 29
physiological aspects (29) 29
prevalence (29) 29
biomarkers (28) 28
physiology (28) 28
double-blind method (27) 27
heart failure - complications (27) 27
usage (27) 27
ventricular dysfunction, left - physiopathology (27) 27
heart attacks (26) 26
heart failure - metabolism (26) 26
biomarkers - blood (25) 25
cardiac patients (25) 25
heart failure - etiology (24) 24
hospitalization (24) 24
ventricular function, left - physiology (24) 24
heart diseases (23) 23
heart failure - blood (23) 23
pulmonary hypertension (23) 23
severity of illness index (23) 23
ventricular function (23) 23
disease models, animal (22) 22
myocardium - metabolism (22) 22
drug therapy (21) 21
health aspects (21) 21
ventricular function, left - drug effects (21) 21
peptide fragments - blood (20) 20
studies (20) 20
incidence (19) 19
predictive value of tests (19) 19
quality of life (19) 19
atrial natriuretic factor - blood (18) 18
clinical trials (18) 18
ejection fraction (18) 18
exercise (18) 18
heart failure - pathology (18) 18
patient outcomes (18) 18
acute disease (17) 17
body mass index (17) 17
cardiovascular diseases (17) 17
heart failure - diagnostic imaging (17) 17
kidney - physiopathology (17) 17
myocardium - pathology (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 06/2009, Volume 54, Issue 1, pp. S85 - S96
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2016, Volume 375, Issue 19, pp. 1868 - 1877
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2011, Volume 58, Issue 6, pp. 629 - 636
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2019, Volume 381, Issue 17, pp. 1609 - 1620
Patients with heart failure with preserved ejection fraction were assigned to receive sacubitril–valsartan or valsartan. At a median of 35 months, there was no... 
MIDDLE CHILD | MIDRANGE | IMPAIRED SYSTOLIC FUNCTION | SPIRONOLACTONE | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Single-Blind Method | Valsartan - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heart Failure - physiopathology | Aminobutyrates - adverse effects | Hospitalization - statistics & numerical data | Male | Tetrazoles - administration & dosage | Cardiovascular Diseases - mortality | Female | Aminobutyrates - administration & dosage | Double-Blind Method | Valsartan - adverse effects | Hypotension - chemically induced | Heart Failure - drug therapy | Stroke Volume | Neprilysin - antagonists & inhibitors | Sex Factors | Quality of Life | Angioedema - chemically induced | Aged | Tetrazoles - adverse effects | Angiotensin Receptor Antagonists - administration & dosage | Angiotensin Receptor Antagonists - adverse effects | Heart failure | Treatment outcome | Care and treatment | Usage | Safety and security measures | Hospitals | Patient outcomes | Analysis | Angiotensin | Causes of | Statistics | Admission and discharge | Renal function | Cardiomyopathy | Mortality | Angioedema | Clinical trials | Hospitalization | Coronary artery disease | Hypotension | Heart rate | Hyperkalemia | Patient safety | Death | Neprilysin | Heart diseases | Pharmaceuticals | Ejection fraction | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2011, Volume 364, Issue 9, pp. 797 - 805
Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2012, Volume 367, Issue 24, pp. 2296 - 2304
Journal Article
Journal Article